MREO vs PGR · $48.7M cap vs P/E 10, rev $45.80B
Mereo BioPharma Group PLC ADR (MREO) versus Progressive Corp (PGR) — a side-by-side from cached financials, not a winner call.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
Progressive Corp (PGR) is a insurance - property & casualty company listed on NYSE.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
Latest reported PGR revenue for 2026-06-30 was $45.80B. Net income was $6.13B. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
MREO currently screens at market cap $48.7M. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
Not investment advice. Open the MREO and PGR stock pages for the full models.
Not investment advice.